²é¿´: 784  |  »Ø¸´: 1
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

christian

ľ³æ (ÕýʽдÊÖ)

[½»Á÷] GMP³£Óôʻã

ÒѾ­ÊÕË÷£¬ÎÞÖØ¸´
GMPÓ¢Óï
PIC/SµÄÈ«³ÆÎª£ºPharmaceutical Inspection Convention/Pharmaceutical Inspection Cooperation Scheme, PIC/S(ÖÆÒ©¼ì²é²Ý°¸), Ò©Æ·¼ì²éЭ»á(PIC/S) ,Ò²ÓÐÈ˳ÆPIC/SΪҽҩÉó²é»áÒé/ºÏ×÷¼Æ»®£¨PIC/S£©
PICµÄȨÍþ·­Ò룺ҩƷÉú²ú¼ì²éÏ໥³ÐÈϹ«Ô¼

API(Active Pharmaceutical Ingrediet) Ô­ÁÏÒ© Óֳƣº»îÐÔÒ©Îï×é·Ö
AirLock ÆøÕ¢ Authorized Person ÊÚȨÈË Batch/Lot Åú´Î
Batch Number/Lot-Number ÅúºÅ£»Batch Numbering System Åú´Î±àÂëϵͳ£»
Batch Records Åú¼Ç¼£»Bulk Product ´ý°ü×°Æ·£»Calibration УÕý£»Clean area½à¾»Çø£»Consignmecnt£¨Delivery£©ÍÐÏúÒ©Æ·¡£

FDA£¨FOOD AND DRUG ADMINISTRATION£©£º£¨ÃÀ¹ú£©Ê³Æ·Ò©Æ·¹ÜÀí¾Ö
IND£¨INVESTIGATIONAL NEW DRUG£©£ºÁÙ´²Ñо¿ÉêÇ루ָÉ걨½×¶Î,Ïà¶ÔÓÚNDA¶ø
ÑÔ£©£»Ñо¿ÖеÄÐÂÒ©£¨Ö¸ÐÂÒ©¿ª·¢½×¶Î£¬Ïà¶ÔÓÚÐÂÒ©¶øÑÔ£¬¼´ÁÙ´²Ç°Ñо¿½áÊø£©
NDA£¨NEW DRUG APPLICATION£©£ºÐÂÒ©ÉêÇë
ANDA£¨ABBREVIATED NEW DRUG APPLICATION£©£º¼ò»¯ÐÂÒ©ÉêÇë
TREATMENT IND£ºÑо¿ÖеÄÐÂÒ©ÓÃÓÚÖÎÁÆ
ABBREVIATED£¨NEW£©DRUG£º¼ò»¯ÉêÇëµÄÐÂÒ©
DMF£¨DRUG MASTER FILE£©£ºÒ©ÎïÖ÷Îļþ£¨³ÖÓÐÕßΪ½÷É÷Æð¼û¶ø×¼±¸µÄ±£ÃÜ×ÊÁÏ£¬¿ÉÒÔ
°üÀ¨Ò»¸ö»ò¶à¸öÈËÓÃÒ©ÎïÔÚÖÆ±¸¡¢¼Ó¹¤¡¢°ü×°ºÍÖü´æ¹ý³ÌÖÐËùÉæ¼°µÄÉ豸¡¢Éú²ú¹ý³Ì»òÎï
Æ·¡£Ö»ÓÐÔÚDMF³ÖÓÐÕß»òÊÚȨ´ú±íÒÔÊÚȨÊéµÄÐÎʽÊÚȨ¸øFDA£¬FDAÔÚÉó²éIND¡¢
NDA¡¢ANDAʱ²ÅÄܲο¼ÆäÄÚÈÝ£©
HOLDER£ºDMF³ÖÓÐÕß
CFR£¨CODE OF FEDERAL REGULATION£©£º£¨ÃÀ¹ú£©Áª°î·¨¹æ
PANEL£º×¨¼ÒС×é
BATCH PRODUCTION£ºÅúÁ¿Éú²ú£»·ÖÅúÉú²ú
BATCH PRODUCTION RECORDS£ºÉú²úÅúºÅ¼Ç¼
POST-OR PRE- MARKET SURVEILLANCE£ºÏúÊÛǰ»òÏúÊÛºó¼à¶½
INFORMED CONSENT£ºÖªÇéͬÒ⣨»¼Õß¶ÔÖÎÁÆ»òÊÜÊÔÕß¶ÔÒ½ÁÆÊÔÑéÁ˽âºó±íʾͬÒâ½ÓÊÜÖÎÁÆ»òÊÔÑ飩
PRESCRIPTION DRUG£º´¦·½Ò©
OTC DRUG£¨OVER¡ªTHE¡ªCOUNTER DRUG£©£º·Ç´¦·½Ò©

GMPÎļþ³£¼ûËõд

ABPI Association of the British Pharmaceutical Industry
ADR Adverse Drug Reaction
AE Adverse Event
AIM Active Ingredient Manufacturer
ANDA Abbreviated New Drug Application
ANOVA Analysis of Variance
ASM: Active Substance Manufacturer
ATC Anatomical Therapeutic Chemical
ATX Animal Test Exemption Certificate
BAN British Approved Name
BIRA British Institute of Regulatory Affairs
BNF British National Formulary
BP British Pharmacopoeia
C of A Certificate of Analysis
C of S Certificate of Suitability
CENTRE FOR DRUG EVALUATION (CDE)
Centre for Pharmaceutical Administration (CPA)
CMS Concerned Member State
CMSÿ¸ö³ÉÔ±¹ú
COS Certificate of Suitability
CPMP Committee for Proprietary Medicinal Products
CRA Clinical Research Associate
CRF Case Report Form
CRO Contract Research Organisation
CTA Clinical Trial Application
CTC Clinical Trial Certificate
CTD Common Technical Document
CTX Clinical Trials Exemption
DDD Defined Daily Dose
DGC Daily Global Comparison
DIA Drug Information Association
DMF Drug Master File
Drug Registration Branch (DR, Product Evaluation & Registration Division, CPA
EDQM (European Directorate for the Quality of Medicines) Å·ÖÞÁªÃËÒ©Æ·ÖÊÁ¿Ö¸µ¼Î¯Ô±»á
EEA Å·ÖÞ¾­¼ÃµØÇø
EGMA European Generics Medicine Association
ELA Established Licence Application
EMEA European Medicines Evaluation Agency
EMEA £¨European Agency for the Evaluation of Medicinal Products£© Å·ÖÞÁªÃËÒ©Æ·ÆÀ¼Û»ú¹¹
EP European Pharmacopoeia
EPAR European Public Assessment Reports
ESRA European Society of Regulatory Affairs
European Pharmacopoeia Commission Å·ÖÞÒ©µäίԱ»á
FDA
FDA Food and Drug Administration
final evaluation report (FER)
free sale certificates (FSCs)
GCP Good Clinical Practice
GCPÒ©Æ·ÁÙ´²Ñо¿¹ÜÀí¹æ·¶
GLP Good Laboratory Practice
GLP Ò©Æ·ÁÙ´²Ç°°²È«ÐÔÑо¿ÖÊÁ¿¹ÜÀí¹æ·¶
GMP Good Manufacturing Practice
GMP Ò©Æ·Éú²úÖÊÁ¿¹ÜÀí¹æ·¶
GSPÒ©Æ·ÏúÊÛ¹ÜÀí¹æ·¶

Health Sciences Authority (HSA)
HSA¡¯s Medicines Advisory Committee (MAC)
IB Investigators Brochure
ICH International Conference for Harmonisation
IDMC Independent Data-Monitoring Committee
IEC Independent Ethics Committee
IND Investigational New Drug
INN International Non-proprietary Name
International Conference on Harmonisation (ICH)
IPC In Process Control
IRB Institutional Review Board
LICENCE HOLDER
MA Marketing Authorisation
MAA Marketing Authorisation Application
MAAÉÏÊÐÉêÇë
MAH Marketing Authorisation Holder
MAH ÏúÊÛÐí¿É³ÖÓÐÕß
MCA Medicines Control Agency
MHW Ministry of Health and Welfare (Japan)
MR Mutual Recognition
MRA ÃÀ¹úÓëÅ·Ã˵Ļ¥ÈÏЭÒé
MRAs (Mutual Recognition Agreements) »¥ÏàÕJ×CͬÒâ
MRFG Mutual Recognition Facilitation Group
MRP Mutual Recognition Procedure
NAS New Active Substance
NCE New Chemical Entity
NDA New Drug Application
new chemical entities (NCEs)
new drug applications (NDAs)
NSAID Non Steroidal Anti Inflammatory Drug
NTA Notice To Applicants
OOS Out of Specification
OTC Over The Counter
PAGB Proprietary Association of Great Britain
Ph Eur European Pharmacopoeia
PIL Patient Information Leaflet
PL Product Licence
POM Prescription Only Medicine
PRODUCT OWNER
PSU Periodic Safety Updates
QA Quality Assurance
QC Quality Control
RAJ Regulatory Affairs Journal
RMS Reference Member State
RMSÏ໥ÈÏ¿ÉÁíÒ»³ÉÔ±¹ú
RSD Relative Standard Deviation
Rx Prescription Only
SAE Serious Adverse Event
SMF Site Master File
SOP Standard Operating Procedure
SOP £¨STANDARD OPERATION PROCEDURE£© ±ê×¼ÔË×÷³ÌÐò
SPC/SmPC Summary of Product Characteristics
summary of product characteristics(SPC)
Therapeutic Goods Administration (TGA)
USP US Pharmacopoeia
VMF Veterinary Master File
VPC Veterinary Products Committee

A£®A£®A  Addition and Amendments  Ôö²¹ºÍÐÞ¶©
AC  Air Conditioner  ¿Õµ÷Æ÷
ADR  Adverse Drug Reaction  Ò©Îï²»Á¼·´Ó¦
AFDO  Association of Food and Drug Officials  Ê³Æ·ÓëÒ©Æ·¹ÙԱЭ»á£¨ÃÀ¹ú£©
ACC  Accept  ½ÓÊÜ
AQL  Acceptable Quality Level  ºÏ¸ñÖÊÁ¿±ê×¼
ADNA  Abbreviated New Drug Application  ¼ò»¯µÄÐÂÒ©ÉêÇë
BOM  Bill of Material  ÎïÁÏÇåµ¥
BPC  Bulk pharmaceutical Chemiclls  Ô­ÁÏÒ©
CBER  Center for Biologics Evaluation Research  ÉúÎïÖÆÆ·ÆÀ¼ÛÓëÑо¿ÖÐÐÄ
CFU  Colony Forming Unet  ¾úÂäÐγɵ¥Î»
DMF  Drug Master File  Ò©Æ·¹ÜÀíµµ°¸
CDER  Cemter for Drug Evaluation amd Research  Ò©ÎïÆÀ¼ÛÓëÑо¿ÖÐÐÄ
CI  Corporate Identity (Image)  Æóҵʶ±ð£¨ÐÎÏó£©
CIP  Cleaning in Place  ÔÚÏßÇåÏ´
CSI  Consumer Safety Insepctor  Ïû·ÑÕß°²È«µ÷²éÔ±
CLP  Cleaning Line Procedure  ÔÚÏßÇåÏ´³ÌÐò
DAL  Defect Action Level  È±ÏÝ×÷ÓÃˮƽ
DEA  Drug Enforcement Adminestration  ¹ÜÖÆÒ©Æ·¹ÜÀí
DS  Documentation Systim  Îļþϵͳ
FDA  Food and Drug Administration  Ê³Æ·ÓëÒ©Æ·¹ÜÀí¾Ö£¨ÃÀ¹ú£©
GATT  General Agreemernt on Tariffs and Trade  ¹ØÃ³×ÜЭ»á
GMP  Good Manufacturing Practice Gvp  Ò©Æ·ÉúÖÊÁ¿¹ÜÀí¹æ·¶
GCP  Good Clinical Practice  Ò©Æ·ÁÙ´²ÊµÑé¹ÜÀí¹æ·¶
GLP  Good Laboratory Practice  ÊµÑéÊÒ¹ÜÀí¹æ·¶
GSP  Good Supply Practice  Ò©Æ·ÉÌÒµÖÊÁ¿¹æ·¶
GRP  Gook RaTAIL Practice  Ò©Æ·ÁãÒµÖÊÁ¿¹ÜÀí¹æ·¶
GAP  Good Agriculture Practice  Ò©²ÄÉú²ú¹ÜÀí¹æ·¶
GVP  Gook Validation Prctice  ÑéÖ¤¹ÜÀí¹æ·¶
GUP  Gook Use Practice  Ò©Æ·ÖØÓù淶
HVAC  Heating Ventilation Air Conditioning  ¿Õµ÷¾»»¯ÏµÍ³
ISO  Intematonal Organization for Standardization  ³µ¼Ê±ê×¼»¯×éÖ¯
MOU  Memorandum of Understanding  Á½ⱸÍü¼
PF  Porduction File  Éú²ú¼Ç¼Óñí¸ñ
OTC  Over the Counter (Drug)  ·Ç´¦·½Ò©Æ·
PLA  Product License Application  ²úÆ·Ðí¿ÉÉêÇë
QA  Quality Assurance  ÖÊÁ¿±£Ö¤
QC  Quality Control  ÖÊÁ¿¿ØÖÆ
QMP  Quality Management Procedure  ÖÊÁ¿¹ÜÀí³ÌÐò
SDA  State Drug Administration  ¹ú¼ÒÒ©Æ·¼à¶½¹ÜÀí¾Ö
SMP  Standard Managmert Procedure  ±ê×¼¹ÜÀí³ÌÐò
SOP  Standard Operating Procedure  ±ê×¼²Ù×÷³ÌÐò
TQC  Tatal Quality Control  È«ÃæÖÊÁ¿¹ÜÀí
USA  Uneted States Pharmacopeia  ÃÀ¹úÒ©µä
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

Äã³öÉúµÄʱºò£¬Äã¿Þ×Å£¬ÖÜΧµÄÈËЦ×Å£»ÄãÊÅÈ¥µÄʱºò£¬ÄãЦ×Å£¬¶øÖÜΧµÄÈËÔÚ¿Þ
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
2Â¥2006-09-24 08:55:11
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ christian µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 295¸´ÊÔµ÷¼Á +3 ¼òľChuFront 2026-03-19 3/150 2026-03-20 09:11 by ÿÌìÖ»°ÚһС»á
[¿¼ÑÐ] Ò»Ö¾Ô¸Î人Àí¹¤²ÄÁϹ¤³Ìר˶µ÷¼Á +6 Doleres 2026-03-19 6/300 2026-03-20 09:03 by xingguangj
[¿¼ÑÐ] 304Çóµ÷¼Á +5 ÂüÊâ2266 2026-03-18 5/250 2026-03-20 09:00 by ZHANG0tao
[¿¼ÑÐ] Ò»Ö¾Ô¸¼ªÁÖ´óѧ²ÄÁÏѧ˶321Çóµ÷¼Á +9 Ymlll 2026-03-18 12/600 2026-03-20 00:01 by 23Postgrad
[¿¼ÑÐ] 288Çóµ÷¼Á +15 ÓÚº£º£º£º£ 2026-03-19 15/750 2026-03-19 22:41 by ѧԱ8dgXkO
[¿¼ÑÐ] ¡¾¿¼Ñе÷¼Á¡¿»¯Ñ§×¨Òµ 281·Ö£¬Ò»Ö¾Ô¸ËÄ´¨´óѧ£¬³ÏÐÄÇóµ÷¼Á +5 ³Ô³Ô³Ô²ÅÓÐÒâÒå 2026-03-19 5/250 2026-03-19 16:18 by 30660438
[¿¼ÑÐ] 266Çóµ÷¼Á +5 ÑôÑôÍÛÈû 2026-03-14 10/500 2026-03-19 15:08 by ÑôÑôÍÛÈû
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷°²½»Í¨´óѧ²ÄÁϹ¤³Ìרҵ 282·ÖÇóµ÷¼Á +5 ·ãÇÅZL 2026-03-18 7/350 2026-03-19 14:52 by ¹¦·ò·è¿ñ
[¿¼ÑÐ] Ò»Ö¾Ô¸Äϲý´óѧ£¬327·Ö£¬²ÄÁÏÓ뻯¹¤085600 +3 Ncdx123456 2026-03-19 3/150 2026-03-19 13:18 by houyaoxu
[¿¼ÑÐ] ²ÄÁÏ¿¼Ñе÷¼Á +3 xwt¡£ 2026-03-19 3/150 2026-03-19 11:22 by wãåÑôw
[¿¼ÑÐ] 0817µ÷¼Á +3 ûÓдð°¸_ 2026-03-14 3/150 2026-03-19 09:51 by Xu de nuo
[¿¼ÑÐ] »¯Ñ§¹¤³Ì321·ÖÇóµ÷¼Á +15 ´óÃ×·¹£¡ 2026-03-15 18/900 2026-03-18 14:52 by haxia
[¿¼ÑÐ] 331Çóµ÷¼Á£¨0703Óлú»¯Ñ§ +7 ZY-05 2026-03-13 8/400 2026-03-18 14:13 by 007_lilei
[¿¼ÑÐ] ¹¤¿Æ²ÄÁÏ085601 279Çóµ÷¼Á +6 À§ÓÚÐdz¿ 2026-03-17 6/300 2026-03-18 10:21 by kkcoco25
[¿¼ÑÐ] 326Çóµ÷¼Á +4 ŵ±´¶û»¯Ñ§½±êéê 2026-03-15 7/350 2026-03-16 17:11 by ŵ±´¶û»¯Ñ§½±êéê
[¿¼ÑÐ] 304Çóµ÷¼Á +3 ÂüÊâ2266 2026-03-14 3/150 2026-03-16 16:39 by houyaoxu
[¿¼ÑÐ] 326Çóµ÷¼Á +3 mlpqaz03 2026-03-15 3/150 2026-03-16 07:33 by Iveryant
[¿¼ÑÐ] ÇóÀÏʦÊÕÁôµ÷¼Á +4 jiang½ª66 2026-03-14 5/250 2026-03-15 20:11 by Winj1e
[¿¼ÑÐ] 297Ò»Ö¾Ô¸ÉϽ»085600Çóµ÷¼Á +5 Ö¸¼â°ËǧÀï 2026-03-14 5/250 2026-03-14 17:26 by a²»Ò×
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +3 ºôºô£¿~+123456 2026-03-14 3/150 2026-03-14 16:53 by WTUChen
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û